News

Latest updates

Follow ExoVectory’s progress across platform development, research milestones, collaborations and company updates.

ExoVectory selected for the NL-USA Health Accelerator Program

ExoVectory joins EVolve-PLN to develop a treatment for PLN cardiomyopathy

ExoVectory joins EVolve-PLN to develop a treatment for PLN cardiomyopathy

Brigitte Bais and Jarik Stoutjesdijk receive ZonMw Young Investigator Award

Brigitte Bais and Jarik Stoutjesdijk receive ZonMw Young Investigator Award

ExoVectory presents at the Life Sciences Café

ExoVectory presents at the Life Sciences Café

ExoVectory awarded Eurostars grant, for development of ex vivo T-cell therapy cancer

ExoVectory awarded Eurostars grant, for development of ex vivo T-cell therapy cancer

Munzur Lacin, PhD student Erasmus MC-ExoVectory receives NLSEV prize

Munzur Lacin, PhD student Erasmus MC-ExoVectory receives NLSEV prize

Jeroen de Vrij, speaker on exosome therapies

ExoVectory’s CSO Jeroen de Vrij presents webinar on exosome therapies with Thermo Fisher Scientific

Team ExoVectory keeps growing

Team ExoVectory keeps growing

Partnership ExoVectory & Erasmus MC: Health Holland funding to develop exosome cancer therapy

Partnership ExoVectory & Erasmus MC: Health Holland funding to develop exosome cancer therapy

Illustration of the brain and genetic research

ExoVectory and Erasmus MC join forces to develop exosome therapy for glioblastoma brain cancer

ExoVectory team

License agreement signed with Erasmus MC

Laboratory research with a multichannel pipette

ExoVectory acquires pre-seed funding ErasSupport